Schizophrenia Flashcards
Other adverse effects of clozapine?
Fever - 55%
Tachycardia - 25%
Hypersalivation - 30-80%
Night time enuresis - 21%
Clozapine range - WBC 3.0-3.5 Neutrophils 1.5-2
Continue Clozapine therapy with twice weekly blood tests
Clozapine range WBC < 3; Neutrophils <1.5
Stop immediately
Contact heme and Clozapine monitoring center
Clozapine range: WBC>3.5; WBC>2
Continue clozapine
Less common side effects of antipsychotics?
Pulmonary embolism
Stroke and cardiac events
Osteoperosis
Impulse control disorders
Mortality in Schizophrenia?
3x greater vs general population
Risk of diabetes in Scz
1.3 fold higher
2 fold greater risk premature death
Risk factors for NMS?
use of high doses parenteral administration physical restraints dehydration older age previous history family history of catatonia
Cardinal symptoms of NMS ?
hyperthermia
rigidity
elevated CPK more than 4x
autonomic dysregulation
Schizophreniform DIsorder
Presence of at least two of the following:
- onset of prominent psychotic symptoms within 4 weeks of the first noticeable change in usual behavior of functioning
- confusion or perplexity
- good premorbid social and occupational functioning
- absence of blunted or flat affect
Further evidence for psychosocial interventions in schizophrenia?
Family intervention Supported employment CBT cognitive remediation social skills training
Signs and symptoms of intracranial pathology
headaches
nausea and vomiting
seizure like activity
late age onset of symptoms
Schizophrenia - etiology and epidemiology - prenatal risk factors
season at birth - winter > summer exposure to influenza in utero birth complications paternal age >35 male gender Urbanicity Migration
Adult onset vs early onset Scz
Adult onset = better prognosis Early onset prognosis measures (worse): - more severe illness - lower premorbid functioning - more severe negative symptoms
Neurophysiology findings in Scz
Reductions in gray matter in these areas - prefrontal - medial temporal - superior temporal - Enlarged ventricles - reduced symmetry gray matter loss related to inflammatory process during synpatic pruning via C4A cytokines more grey matter loss in chronic patients
Neurophysiology findings in Sz
reduced amplitude of p300 p50 evoked potentials - very consistent findings
reduced sleep spindles on EEG
abnormal EEG present at baseline in 15-25% patients with first episode psychosis
Abnormal EEG findings at onset of illness is related to worse outcome at 3 and 5 year follow up measures:
- Positive symptoms
- Negative symptoms
- Overall level of functioning (as measured by SOFAs)
What are neurochemical findings in Scz?
increased striatal dopamine on PET scanning in acute psychosis
NMDA receptors and loss of GABA -ergic functioning in cortical neurons - positive and negative symptoms
GLutamate is likely implicated
CBD may be protective
Good prognostic indicators for schizophrenia
Shorter duration of untreated psychosis Fewer negative symptoms predominately only delusions and hallucinations as positive symptoms Higher baseline premorbid functioning Absence of ACE No co-occuring psychiatric disorders (including substance use disorder) Absent family history of schizophrenia Present family history of mood disorder
History of childhood trauma - risk for psychosis?
3x
Possible causes of high level comorbidity scz and substance use disorders?
Temporary compensation of D2 blockade caused by antipsychotics
Share vulnerability to both illnesses
Self medication
Increased risk of psychotic illness secondary to drug use
What is the strongest predictor of social and vocational outcomes in Scz?
Cognitive deficits - 100% show vs premorbid level
Cognitive remediation
- 2 main approaches - restorative (through repetition)
- strategy circumventing deficits
Ultra High Risk - Prodrome
onset of attenuated positive symptoms not reaching threshold for psychosis
brief intermittent psychotic symptoms lasting less than 7 days
combination of trait (positive family history of psychosis in first degree relative) and significant decline in global functioning in previous year.
UHR - shown transition to psychosis at the rate of around 25-35% in the first year
Ultra High Risk
must be aged between 15-25 yerars old
must have been referred to a specialized service for help
meet criteria for one or more of the following three groups:
Attenuated Positive Symptoms
Brief limited Intermittent psychotic symptoms (BLIPs)
Trait and state risk factors
APS - attenuated positive symptoms
Group 1:
Presence of at least one of the following symptoms:
ideas of reference, odd beliefs, magical thinking, perceptual disturbance, paranoid ideation, odd thinking and speech, odd behavior and appearance
- Frequency of symptoms: at least several times a week
- Recency of symptoms: present within last year
- Duration of symptoms: present for at least 1 week and no longer than 5 years.
Brief limited intermittent psychotic symptoms (BLIPS)
Group 2:
Transient psychotic symptoms: presence of at least one of the following: IOR, magical thinking, perceptual disturbance, odd thinking
Duration of episode: less than 1 week
Frequency: at least several times per week, resolve spontaneously
Recency: must have occurred within last year
Trait and state risk factors
Group 3
Schizotypal personality disorder or first degree relative with ap ychotic disorder
Significant decline in mental state or functioning, maintained for at least 1 month not longer than 5 years
- This decline in functioning must have occured in teh past year
What is conversion rate of UHR?
10-18%
Treatment Guidelines?
Following resolution of positive symptoms of first episodes, what should be the duration of treatment for maintenance ?
the duration should be at least 18 months
What is the duration of treatment after relapse?
patients should be offered medication 2 to 5 years or longer
Risk of second episode of psychoses - Scz
At least 80% with first episode psychosis are at risk for second episode within first 3-5 years, recovery from second episode is slower
Predictors of relapse
Medication nonadherence - 4 fold
persistent substance use - 3 fold
careers critical comments - 2.3 fold
poor premorbid ajdustment - 2.2 fold
5 As schizohprenia
avolition, apathy, anhedonia, affect flat, asociality